BR0108261A - Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono - Google Patents

Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono

Info

Publication number
BR0108261A
BR0108261A BR0108261-2A BR0108261A BR0108261A BR 0108261 A BR0108261 A BR 0108261A BR 0108261 A BR0108261 A BR 0108261A BR 0108261 A BR0108261 A BR 0108261A
Authority
BR
Brazil
Prior art keywords
treatment
mirtazapine
individual
sleep
treating
Prior art date
Application number
BR0108261-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Gerardus Stephanus Franc Ruigt
Frans Van Den Berg
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0108261A publication Critical patent/BR0108261A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR0108261-2A 2000-02-11 2001-02-06 Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono BR0108261A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200499 2000-02-11
PCT/EP2001/001221 WO2001058453A1 (en) 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders

Publications (1)

Publication Number Publication Date
BR0108261A true BR0108261A (pt) 2003-03-05

Family

ID=8171013

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108261-2A BR0108261A (pt) 2000-02-11 2001-02-06 Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono

Country Status (25)

Country Link
US (1) US6933293B2 (enExample)
EP (4) EP1257278B1 (enExample)
JP (1) JP5039994B2 (enExample)
KR (1) KR20020069371A (enExample)
CN (2) CN1395487A (enExample)
AR (1) AR027394A1 (enExample)
AT (1) ATE317261T1 (enExample)
AU (1) AU780439B2 (enExample)
BR (1) BR0108261A (enExample)
CA (1) CA2396209C (enExample)
CO (1) CO5271706A1 (enExample)
CZ (1) CZ302368B6 (enExample)
DE (1) DE60117122T2 (enExample)
DK (1) DK1257278T3 (enExample)
ES (1) ES2258071T3 (enExample)
HK (1) HK1049122B (enExample)
HU (1) HUP0204391A3 (enExample)
IL (2) IL150290A0 (enExample)
NO (1) NO328007B1 (enExample)
PE (1) PE20011080A1 (enExample)
PL (1) PL206073B1 (enExample)
RU (1) RU2270680C2 (enExample)
SK (1) SK287396B6 (enExample)
WO (1) WO2001058453A1 (enExample)
ZA (1) ZA200205238B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152055A1 (en) * 2003-01-30 2004-08-05 Gliessner Michael J.G. Video based language learning system
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US20070298107A1 (en) * 2003-11-25 2007-12-27 Aurobindo Pharma Ltd. Pharmaceutical Compositions of Mirtazapine
GB0417558D0 (en) * 2004-08-06 2004-09-08 Merck Sharp & Dohme Novel combination therapy
AU2005292853C1 (en) * 2004-10-14 2010-08-05 Daikin Industries, Ltd. Atmosphere modifying method and spray agent and spray device used in the same
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
JP2007284363A (ja) * 2006-04-13 2007-11-01 Daikin Ind Ltd 噴霧剤
EP2146993B1 (en) 2007-04-11 2015-08-05 Merck Sharp & Dohme B.V. A method for the preparation of mirtazapine
PT3261645T (pt) 2015-02-27 2021-06-17 Dechra Ltd Estimulação do apetite, gestão da perda de peso, e tratamento da anorexia em cães e gatos
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
HU215410B (hu) * 1992-10-07 1998-12-28 Akzo N.V. Eljárás enantiomerek elkülönítésére racém elegyből
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
DK1030667T3 (da) 1997-11-14 2005-06-20 Akzo Nobel Nv Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö

Also Published As

Publication number Publication date
KR20020069371A (ko) 2002-08-30
CZ20022330A3 (cs) 2002-11-13
EP1658850A1 (en) 2006-05-24
HUP0204391A2 (en) 2003-05-28
CA2396209C (en) 2009-09-01
PL356721A1 (en) 2004-06-28
CN1395487A (zh) 2003-02-05
CO5271706A1 (es) 2003-04-30
RU2270680C2 (ru) 2006-02-27
ES2258071T3 (es) 2006-08-16
CZ302368B6 (cs) 2011-04-13
SK287396B6 (sk) 2010-08-09
JP5039994B2 (ja) 2012-10-03
US6933293B2 (en) 2005-08-23
EP1656937A1 (en) 2006-05-17
IL150290A (en) 2010-12-30
AR027394A1 (es) 2003-03-26
SK11442002A3 (sk) 2003-02-04
EP1257278B1 (en) 2006-02-08
ATE317261T1 (de) 2006-02-15
PE20011080A1 (es) 2001-10-18
HUP0204391A3 (en) 2005-03-29
NO20023803L (no) 2002-10-09
US20030022888A1 (en) 2003-01-30
IL150290A0 (en) 2002-12-01
HK1049122A1 (en) 2003-05-02
CN101229170A (zh) 2008-07-30
EP1257278A1 (en) 2002-11-20
DE60117122D1 (de) 2006-04-20
DK1257278T3 (da) 2006-06-12
PL206073B1 (pl) 2010-06-30
ZA200205238B (en) 2003-09-29
AU3024701A (en) 2001-08-20
NO328007B1 (no) 2009-11-09
AU780439B2 (en) 2005-03-24
HK1049122B (en) 2006-04-21
CA2396209A1 (en) 2001-08-16
NO20023803D0 (no) 2002-08-09
DE60117122T2 (de) 2006-07-27
RU2002124141A (ru) 2004-03-10
EP2283840A1 (en) 2011-02-16
WO2001058453A1 (en) 2001-08-16
JP2003522147A (ja) 2003-07-22

Similar Documents

Publication Publication Date Title
YU30004A (sh) Upotreba flibanserina u lečenju seksualnih poremećaja
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
MXPA05008649A (es) Terapia de combinacion para el tratamiento de desordenes inmunoinflamatorios.
BRPI0418029A (pt) formulação de anticorpos cd40 e métodos
ES2165990T3 (es) Thip para el tratamiento de trastornos del sueño.
TR200001891T2 (tr) ASPB28- İnsan ensülini ve kullanımı.
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
BR0109779A (pt) Soluções moleculares hidrofìlicas dispersas de carvedilol
BR0115162A (pt) Tratamentos antitumorais eficazes
EE200200107A (et) Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
BR0208421A (pt) Formulação farmacêutica para administração a um paciente através das mucosas, dose farmacêutica diária, dispersão sólida, uso de pvp em dispersão sólida com 4'-ciano-alfa', alfa', alfa'-trifluoro-3-(4-fluoro fenilsulfonil)-2-hidróxi-2-metilpropiono-m-toluidet o, e, métodos para aumentar a estabilidade em armazenagem, a biodisponibilidade da droga e para reduzir a variação de concentrações de plasma do 4'-ciano-alfa', alfa', alfa',-trifluoro-3-(4-fluorofenilsulfonil)-2-hidróxi-2 -metilpropiono-m-toluideto entre pacientes
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
NO20055531L (no) Preparat for forbedret kognisjon og hukommelse
GB0020504D0 (en) Therapeutic method
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
BR0009380A (pt) Tratamento de câncer melhorado comtemozolomida
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
AR027394A1 (es) Uso de mirtazapina para el tratamiento de trastornos del sueno
BRPI0408500A (pt) tratamento do diabetes do tipo 1 com inibidores de pde5
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
BR0208488A (pt) Agonistas de kapa-opiato para o tratamento de doenças da bexiga
PT1251850E (pt) Utilizacao de uma preparacao de combinacao na terapia do cancro
ATE347364T1 (de) Quetiapin zur behandlung der dyskinesie in nicht- psychotischen patienten

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11 E 13 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.